Dr. Rupan Trikha

Dr. Trikha holds his medical doctorate from the University of Medicine and Dentistry of New Jersey, New Jersey Medical School. Dr. Trikha served as the Chief Resident of Ophthalmology at Geisinger Medical Center in Danville, Pennsylvania and is a Rutgers University of New Brunswick alumnus, where he studied for both his undergraduate and graduate degrees.

Articles by Dr. Trikha

1. Retinal Physician - Endoscopic Vitrectomy for Treating Endophthalmitis (June 2019)
2. Retina Today - Why Small-Gauge Endoscopy Should Not Be Overlooked (May/June 2017)
3. Ocular Surgery News - Endoscope an Essential Instrument for every Retina Surgeon (June 2017)

Education

Medical Training

Hospital and Facility Affiliations

Employment History

Certification & Licensure

• American Board of Ophthalmology Certification | 2008 - Present
• New Jersey State Medical License | 2011 - Present
• Pennsylvania State Unrestricted Medical License | 2009 - 2011
• California State Medical License | 2007 - 2010
• Pennsylvania State Unrestricted Medical License | 2006
• USMLE Steps I, II, III - Passed | 2004

Honors & Awards

• Patient Satisfaction Award, Geisinger Medical Center, Danville PA | 2010
• Chief Resident of Ophthalmology, Geisinger Medical Center, Danville PA | 2006-2007
• Student Director of Neuroscience Summer Research Program, New Jersey Medical School, Newark, NJ | 2000

International Projects

Publications

• Trikha R. Endoscopic Vitrectomy for Treating Endophthalmitis: Visualization with an endoscope and a wide-angle system is a clear advantage. Retinal Physician. Volume: 16, Issues 16: June 2019.
• Trikha R. Why Small-Gauge Endoscopy should not be overlooked. Retina Today. May/June 2017
• Trikha R. The Endoscope is an essential instrument for every retina surgeon. Ocular Surgery News. June 2017
• Trikha R, Morse LS, Zawadzki RD, Werner JS, Park SP. Ten-year Follow-up of Eyes Treated with Stereotactic-Fractionated External Beam Radiation for Neovascular Age-related Macular Degeneration. Retina 2011;31(7):1303-1315.
• Eric K Chin, Rupan Trikha, Lawrence S Morse, Robert J Zawadzki, John S Werner, Susanna S Park Optical Coherence Tomography Findings of Exophytic Retinal Capillary Hemangiomas of the Posterior Pole. Ophthalmic Surg Lasers Imaging. 2010;Mar 9:1-5
• Trikha R, Yeung CC, Modjtahedi SP, Telander DG. Evaluation of 25-Gauge and 20-Gauge Vitrectomy on cell viability and diagnostic yield for B-cell lymphoma in culture using flow cytometry. Retina 2010;30:1505-1510
• Rupan Trikha, Isabella Thomas, Robert A. Schwartz. Poison ivy dermatitis. Dermatologia Kliniczna 2003, 5(1):7-10.

Chapter Publications

• Rupan Trikha, Nicole Beharry and David G. Telander. Chapter Publication April 4, 2012: Small Gauge Pars Plana Vitrectomy, Vitrectomy, Dr. Zongming Song (Ed.), ISBN: 978-953-51-0546-6, InTech Publications.
• Rupan Trikha, Nicole Beharry and David G. Telander. Chapter Publication April 4, 2012: Small Gauge Pars Plana Vitrectomy, Vitrectomy, Dr. Zongming Song (Ed.), ISBN: 978-953-51-0546-6, InTech Publications.

Abstracts

• Chin EK, Trikha R, Morse L, Zawadzki RJ, Werner JS, Park SS. Optical coherence tomography findings of exophytic retinal capillary hemangiomas of the posterior pole.  Association for Research in Vision and Ophthalmology annual meeting, Fort Lauderdale, FL, May 7, 2009.
• Trikha R, Yeung CC, Modjtahedi SP, Telander DG. Evaluation of 25 Gauge and 20 Gauge Vitrectomy on cell viability and diagnostic yield for B-cell lymphoma in culture using flow cytometry.  Accepted for poster presentation, Association for Research in Vision and Ophthalmology annual meeting, Fort Lauderdale, FL, May 7, 2009.
• Trikha R, Morse LS, Ryu J, Telander DG, Park SS. Long-term follow up on patients treated with stereotactic external beam radiation for exudative age-related macular degeneration.  Poster Presentation, Combined American Academy of Ophthalmology and European Society of Ophthalmology meeting, Atlanta, GA, November 9, 2008.
• Trikha R, Morse LS, Zawadzki RJ, Ryu J, Telander DG, Choi SS, Werner JS, Park SS. Long-term follow-up and High Resolution Fourier-domain Optical Coherence Tomographic Imaging of Eyes Treated with Stereotactic Fractionated External Beam Radiation for Neovascular Age-related Macular Degeneration. Paper presentation, American Society of Retina Specialists annual meeting, Maui, HI, October 12, 2008.
• Trikha R, Morse LS, Ryu J, Telander DG, Park SS. Long-term follow up on patients treated with stereotactic external beam radiation for exudative age-related macular degeneration.  Poster Presentation, Association for Research in Vision and Ophthalmology annual meeting, Fort Lauderdale, FL, April 2008.
• Trikha R, Marks SJ. Retinal boxcarring in a case of hemolytic anemia with cold agglutinin disease.  Video Presentation, American Academy of Ophthalmology annual meeting 2007.
• Trikha R, Guruswami A. Multiple cranial nerve palsies in a case of Neuroborriliosis.  Poster Presentation, North American Neuro-ophthalmology society (NANOS) annual meeting 2005.

Clinical Trials

• Cognoptix PRT-0037.
  Co-Investigator: April 2016 - Present
  A Phase 3 Study Assessing Agreement between the SAPPIRE II System Measuring Amyloid Burden in the Lens of the Eye and PET Amyloid Brain Imaging.
• AZD3293 for the treatment of Alzheimers.
  The AMARANTH Study. CO - INVESTIGATOR: 2014 - Present.
  A 24-month, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy, Safety, Tolerability, Biomarker, and Pharmacokinetic Study of AZD3293 in Early Alzheimer's Disease (The AMARANTH Study)
• Lucentis for Age Related Macular Degeneration
  HORIZON / Extension of MARINA Study. CO - INVESTIGATOR: 2007 - 2009
  An Open-Label, Multicenter Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects with Subfoveal Choroidal Neovascular Membrane (CNV) Secondary to Age-Related Macular Degeneration (AMD) Who Have Completed the Treatment Phase of a Genentech-Sponsored Ranibizumab Study (HORIZON FVF3426g).
• Lucentis for Age Related Macular Degeneration
  DNA Repository Study in Association with Study FVF3426g. CO - INVESTIGATOR: 2007 - 2009 An Open-Label, Multicenter Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects with Choroidal Neovascularization [CNV] Secondary to Age-Related Macular Degeneration [AMD] Who Have Completed the Treatment Phase of a Genentech-Sponsored Ranibizumab Study.
• Anacortave Acetate for Age Related Macular Degeneration
  Anacortave Acetate Risk-Reduction Trial (AART). CO - INVESTIGATOR: 2007 - 2009
  An Evaluation of Efficacy and Safety of Posterior Juxtascleral Administrations of Anecortave Acetate for Depot Suspension (15 mg or 30 mg) versus Sham Administration in Patients (Enrolled in Study “A” or Study “B”) at Risk for Developing Sight-Threatening Choroidal Neovascularization (CNV) Due to Exudative Age-Related Macular Degeneration (AMD).
• Posurdex for Retinal Vein Occlusion
  POSURDEX for CRVO (009). CO - INVESTIGATOR: 2007 - 2009
  A Six-Month, Phase 3, Multicenter, Masked, Randomized, Sham-Controlled Trial (With Six-Month Open-Label Extension) to Assess the Safety and Efficacy of 700 ºg and 350 ºg Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) Applicator System in the Treatment of Patients with Macular Edema Following Central Retinal Vein Occlusion or Branch Retinal Vein Occlusion (Protocol 206207-009).
• AREDS II Vitamins for Age Related Macular Degeneration
  AREDS II Vitamin Study. CO - INVESTIGATOR: 2007 - 2009
  Age-Related Eye Disease Study 2 (AREDS2): A Multi-center, Randomized Trial of Lutein, Zeaxanthin, and Omega-3 Long-Chain Polyunsaturated Fatty Acids (Docosahexaenoic Acid [DHA] and Eicosapentaenoic Acid [EPA]) in Age-Related Macular Degeneration
• POSURDEX for Diabetic Retinal Edema (009). CO - INVESTIGATOR: 2007 - 2009
  A 3-Year, Phase 3, Multicenter, Masked, Randomized, Sham-Controlled Trial to Assess the Safety and Efficacy of 700 ºg Dexamethasone Posterior Segment Drug Delivery System (DEX PS DDS) Applicator System in the Treatment of Patients with Diabetic Macular Edema (Protocol 206207-010)
• Proton Beam with Lucentis for Age Related Macular Degeneration
  CO - INVESTIGATOR: 2007 - 2009
  Phase I Pilot, Open Label, Prospective Observational Study of Safety and Tolerability of Lucentis Combined with Proton Beam Radiation in Treating Exudative Age-Related Macular Degeneration.
• Lucentis versus Laser for Diabetic Macular Edema
  RISE STUDY. CO - INVESTIGATOR: 2007 - 2009
  A Phase III, Double-Masked, Multicenter, Randomized, Sham Injection-Controlled Study of the Efficacy and Safety of Ranibizumab Injection compared to Laser Photocoagulation in Subjects with Clinically Significant Macular Edema with Center Involvement Secondary to Diabetes Mellitus
• Lucentis versus Avastin for Treatment of Wet Age Related Macular Degeneration
  Comparison of AMD Treatment Trials (CATT): Lucentis-Avastin Trial.
  CO - INVESTIGATOR: 2007 - 2009
  Clinical trial comparing efficacy of bevacizumab versus ranibizumab for exudative age-related macular degeneration with PRN and monthly dosing.
• OCT Comparison Study
  Comparison of Optic Nerve and Macular Thickness and Morphology
  CO - INVESTIGATOR: 2007 - 2009
  Comparison of optic nerve and macular morphology among commercially available fourier-domain Optical Coherence Tomography units.
• Lucentis for Diabetic Macular Edema
  DNA Repository Substudy in Association with RISE Study:
  CO - INVESTIGATOR: 2007 - 2009
  Ranibizumab Study FVF4170g (A Phase III, Double-Masked, Multicenter, Randomized, Sham Injection-Controlled Study of the Efficacy and Safety of Ranibizumab Injection in Subjects with Clinically Significant Macular Edema with Center Involvement Secondary to Diabetes Mellitus).
• Macugen for Age Related Macular Degeneration
  LEVEL Study: CO - INVESTIGATOR: 2007 - 2009
  A Phase IV, Open label, Multi-Center Trial of Maintenance Intravitreous Injections of Macugen® (Pegaptanib Sodium) Given Every 6 Weeks for 48 Weeks in Subjects with Subfoveal Neovascular Age-Related Macular Degeneration (AMD) Initially Treated with a Modality Resulting in Maculopathy Improvement. Study EOP1023
• CNTF3 for Retinitis Pigmentosa
  CO - INVESTIGATOR: 2007 - 2009
  A Phase II/III Study of Encapsulated Human NTC-201 Cell Implants Releasing Ciliary Neurotrophic Factor (CNTF) for Participants with Retinitis Pigmentosa Using Visual Acuity as the Primary Outcome - Protocol Designation CNTF-3
• CNTF4 for Retinitis Pigmentosa:
  CO - INVESTIGATOR: 2007 - 2009
  A Phase II/III Study of Encapsulated Human NTC-201 Cell Implants Releasing Ciliary Neurotrophic Factor (CNTF) for Participants with Retinitis Pigmentosa Using Visual Field Sensitivity as the Primary Outcome - Protocol Designation CNTF-4

Selected Platform Presentations

• Peripheral Retinal Disease. Invited Lecturer. Monmouth -; Ocean Counties Society of Optometric Physicians (MOSOP) continuing medical education lecture series. Jumping Brook Country Club Neptune, NJ. November 19, 2018
• OCT for Macular Disease. Invited Lecturer. Dr. Ilan Cohen Continuing Medical Education Series. Grand Marquis, Old Bridge, NJ. March 11, 2018
• Update on Diabetic Retinopathy. Invited Lecturer. Monmouth -; Ocean Counties Society of Optometric Physicians (MOSOP) continuing medical education lecture series. Jumping Brook Country Club Neptune, NJ. October 16, 2017
• Oral Medications and Related Ocular Toxicities. Presenting Lecturer. Monmouth Retina Consultants, NJ Continuing Medical Education lecture series. Physician Education on ocular toxicities from oral medications. Toms River , NJ. February 28, 2018
• Oral Medications and Related Ocular Toxicities. Key Speaker. Monmouth Retina Consultants, Continuing Medical Education lecture series. Lecture for eye care professionals to provide education on ocular toxicities from specific oral medications, including Plaquenil. Little Silver, NJ. November 16, 2016.
• Update on Diabetic Retinopathy. Guest Speaker. Monmouth-Ocean County Society of Optometric Physicians (MOSOP) continuing medical education lecture series. Jumping Brook Country Club, Neptune, NJ. March 21, 2016.
• Oral Medications in Eye Care. Guest Speaker. Monmouth-Ocean County Society of Optometric Physicians (MOSOP) continuing medical education lecture series. Jumping Brook Country Club, Neptune, NJ. October 19, 2015.
• Optical Coherence Tomography (OCT) in Macular Disease. Guest Speaker. Monmouth Retina Consultants continuing medical education lecture series. Lecture provided to primary eye care physicians in Monmouth and Ocean counties. Little Silver, NJ. August 10, 2015.
• Emergency Medicine Grand Rounds: Ophthalmic Emergencies. Guest Speaker. Department of Emergency Medicine, Newark Beth Israel Medical Center, Newark, NJ. June 3, 2015.
• Oral Medications in Ophthalmology, Annual Lecture, New Jersey Academy of Optometry. Jumping Brook Country Club, Neptune, NJ. August 8, 2014.
• Keynote speaker. Age-related Macular Degeneration, A New Era in Management for Optometrists. Joseph C Toland Excellence in Education Lecture. Salus University, Elkins Park, PA. May 4, 2014
• Age-related macular degeneration: Diagnosis, prevention, and treatment. Guest Speaker. Danville Community Center, Danville, PA. August 19, 2009.
• Comparison of 25G and 20G Vitrectomy on Diagnostic Yield for B-Cell Lymphoma. University of California, Davis Medical Center, Annual Napa Valley Symposium, Napa Valley, CA. May 15, 2009.
• Long-term follow-up and High Resolution Fourier-domain Optical Coherence Tomographic Imaging of Eyes Treated with Stereotactic Fractionated External Beam Radiation for Neovascular Age-related Macular Degeneration. Paper presentation, American Society of Retina Specialists annual meeting, Maui, HI, October 2008. Also presented at University of California, Davis Medical Center, Annual Napa Valley Symposium, Napa Valley, CA, April 27, 2008.
• Stargardts Disease. Retinal Degeneration Grand Rounds, University of California Davis Medical Center, Sacramento, CA, April 3, 2009.
• Retinoblastoma. Grand Rounds Presentation, 2008. University of California, Davis Medical Center, Sacramento, CA, April 2008
• Update on Focal Treatment for Retinoblastoma. Tumor Board Conference 2008. University of California, Davis Medical Center
• Syphilis Chorioretinitis. Brazil Telemedicine Grand Rounds 2008. University of California, Davis Medical Center, Sacramento, CA, November 2007.
• Recurrent Conjunctival Melanosis, Shields Ocular Oncology Conference 2007. Geisinger Medical Center.
• Retinopathy of Prematurity, Ophthalmology Grand Rounds 2007 Geisinger Medical Center.
• Eye Care in India, Aravind Eye Hospital, Tamil Nadu, India 2006. Geisinger Medical Center
• Case Report: Cone-Rod dystrophy. Retina Conference 2005. Geisinger Medical Center.
• Case Report: Unusual Case of Neuroborriliosis. Resident Research Day 2005. Geisinger Medical Center, Danville, PA.

Volunteer and Community Service